Metabolic dysfunction-associated steatohepatitis (MASH) significantly increases the risk of liver cirrhosis and ...

Semaglutide — the active substance in Ozempic and Wegovy — may help reduce alcohol cravings in people with alcohol use ...

Peptide therapy enhances targeted medicine, utilizing specific peptides for effective treatment of cancer, metabolic disorders, and neurodegenerative diseases.

A recent study from the University of Pennsylvania has confirmed that the injectable medication semaglutide can lead to major ...

Research reveals semaglutide's effectiveness in decreasing alcohol consumption and cravings, highlighting its potential for ...

The Janus Henderson Global Life Sciences Fund returned -11.16% and the MSCI World Health Care IndexSM returned -11.40%. Click ...

The blockbuster drug semaglutide, better known as Ozempic for diabetes and Wegovy for obesity, could also help people cut ...

Recent research suggests that a new approach could help even patients with advanced forms of fatty liver disease.

"Adherence improves when treatment integrates easily into patients’ lives," explains Adam McBride, Eden’s CEO. Eden’s digital ...

It usually happens over a long period, often due to hepatitis, alcohol use disorder, or metabolic dysfunction-associated steatotic liver disease (MASLD), formerly called non-alcoholic fatty liver ...

Here, we argue that metabolic dysfunction-associated steatotic liver disease should be considered a non-communicable disease.

Most people regain some of the weight they lost after stopping semaglutide ... “Obesity is a chronic disease, and when using medications for treatment, they are intended for long-term use ...